Marina Roytman

Marina Roytman, MD, is an expert in the field of hepatology, serving as a Health Sciences Clinical Professor at the University of California-San Francisco. With a robust background in Internal Medicine and specialized fellowship training in Medical Education, Dr. Roytman has carved a niche for herself in the study and treatment of liver diseases. Her primary research interests include viral hepatitis, autoimmune hepatitis, and drug-induced liver injury, areas in which she has made significant contributions through both clinical practice and academic research. Dr. Roytman's dedication to her field is reflected in the numerous awards she has received for her insightful presentations on hepatitis and drug-induced liver injury. Her commitment to advancing medical knowledge and education is further demonstrated by her roles as Hepatology Elective Supervisor and Moderator for the Hepatobiliary Journal and Research Club. These positions allow her to mentor the next generation of medical professionals while staying at the forefront of hepatology research and practice. As a respected member of the American Association for the Study of Liver Disease and an elected fellow of the American College of Physicians, Dr. Roytman is actively involved in the broader medical community. Her participation in these organizations underscores her dedication to the advancement of liver disease research and treatment, as well as her commitment to maintaining the highest standards of medical practice. Beyond her professional achievements, Dr. Roytman is known for her diverse interests and talents. She is fluent in Russian, which enriches her ability to connect with a broader patient demographic and engage in international collaborations. In her personal time, she enjoys practicing yoga, which complements her professional life by promoting balance and well-being. Additionally, she is passionate about reading and creative writing, pursuits that allow her to explore new ideas and express her creativity. Dr. Roytman's multifaceted career and personal interests make her a well-rounded and dynamic figure in the field of hepatology. Her contributions to medical education and liver disease research continue to impact the field positively, and her dedication to her patients and students is unwavering. As she continues her work at UCSF, Dr. Roytman remains a leading voice in the study and treatment of liver diseases, inspiring both her colleagues and the medical community at large.